Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific—Asia-Pacific Burden of Respiratory Diseases Study-Reference-Cited by-同舟云学术

Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific—Asia-Pacific Burden of Respiratory Diseases Study

Published:2016-05 Issue: Volume:9 Page:72-77
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Wang De Yun,Ghoshal Aloke Gopal,Bin Abdul Muttalif Abdul Razak,Lin Horng-Chyuan,Thanaviratananich Sanguansak,Bagga Shalini,Faruqi Rab,Sajjan Shiva,Brnabic Alan J.M.,Dehle Francis C.,Cho Sang-Heon

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference25 articles.

1. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive report,2007

2. Economic burden of asthma: a systematic review;Bahadori;BMC Pulm Med,2009

3. Contemporary assessment of the disease burden of sinusitis;Bhattacharyya;Am J Rhinol Allergy,2009

4. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States;Bhattacharyya;Laryngoscope,2011

5. Economic analysis of the confronting COPD survey: an overview of results;Wouters;Respir Med,2003

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life and its determinants in patients with chronic respiratory diseases in the Fes-Meknes region, Morocco;Monaldi Archives for Chest Disease;2024-09-12

2. Network pharmacology analysis of the Huangqi-Gancao herb pair reveals quercetin as a therapeutics for allergic rhinitis via the RELA-regulated IFNG/IRF1 axis response;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-12

3. Continual Monitoring of Respiratory Disorders to Enhance Therapy via Real-Time Lung Sound Imaging in Telemedicine;Electronics;2024-04-26

4. Network pharmacology analysis of Huangqi reveals quercetin as a therapeutic for allergic rhinitis via the RELA-regulated IFNG/IRF1 axis response;2024-03-21

5. Real-World Evaluation of the Safety and Effectiveness of 2.3% Hypertonic Saline Soft Mist Spray for Sino-Nasal Symptoms;Cureus;2024-03-01